MorphoSys AG buy OldOrangeEyes
Start price
29.11.23
/
50%
€20.27
Target price
29.11.24
-
Performance (%)
235.47%
Price
19:05
€68.00
Summary
This prediction is currently active. The BUY prediction by OldOrangeEyes for MorphoSys AG has seen massive gains of 235.47%. This prediction currently runs until 29.11.24. The prediction end date can be changed by OldOrangeEyes at any time. OldOrangeEyes has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| MorphoSys AG | -0.075% | -0.075% |
| iShares Core DAX® | 2.749% | 4.620% |
| iShares Nasdaq 100 | 0.470% | -0.331% |
| iShares Nikkei 225® | -2.930% | -5.556% |
| iShares S&P 500 | 0.679% | 0.631% |